These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3383985)

  • 1. Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency.
    Kirsten R; Heintz B; Nelson K; Sieberth HG; Oremek G; Hasford J; Speck U
    Eur J Clin Pharmacol; 1988; 34(2):133-7. PubMed ID: 3383985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting.
    Schuitemaker GE; van der Pol GA; Aretz CP; Dinant GJ
    Eur J Clin Pharmacol; 2001 Mar; 56(12):857-63. PubMed ID: 11317472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium pyridoxal-5'-phosphate glutamate, "A vitamin B6 derivative", does not affect lipoprotein levels in patients with familial hypercholesterolaemia.
    Knipscheer HC; Kindt I; van den Ende A; Nurmohamed MT; Smalbraak H; Mulder WJ; Kastelein JJ
    Eur J Clin Pharmacol; 1997; 51(6):499-503. PubMed ID: 9112067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of magnesium pyridoxal 5-phosphate glutamate in rabbits developing hypercholesterolemia.
    Panagiotopoulos T; Ketelsen UP; Schmidt A; Heuck CC
    Arzneimittelforschung; 1986 Aug; 36(8):1210-5. PubMed ID: 3778558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )].
    Wieland H
    Fortschr Med; 1990; 108 Spec No 1():52-3. PubMed ID: 2245961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dyslipidemia in renal failure].
    Fujioka T; Ueno T; Matsumoto T; Watanabe H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of magnesium pyridoxal 5-phosphate glutamate on vascular reactivity in experimental hypercholesterolemia.
    Khayyal MT; Khayyal MA; Sharaf HM; el-Sherbeeny M; Okpanyi SN; Schneider W
    Drugs Exp Clin Res; 1998; 24(1):29-40. PubMed ID: 9604146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia.
    Dean JD; McCarthy S; Betteridge DJ; Whately-Smith C; Powell J; Owens DR
    Diabet Med; 1992; 9(7):611-5. PubMed ID: 1511566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Jiangzhi koufu ye in the treatment of essential hyperlipemia].
    Liu J; Chang JJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Nov; 13(11):658-60, 643-4. PubMed ID: 8155940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperlipidaemic effects of Eugenia jambolana fruit in diet induced hyperlipidaemic rats.
    Bilal R; Zakaria M; Usman A; Aftab S; Zia A
    J Pak Med Assoc; 2011 May; 61(5):433-7. PubMed ID: 22204172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlipidaemia and cardiovascular disease.
    Sussekov AV
    Curr Opin Lipidol; 1998 Apr; 9(2):175-7. PubMed ID: 9559278
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofibrate and lipid profile.
    Chandler HA; Batchelor AJ
    Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of gemfibrozil (Lopid) on hyperlipidemia in acitretin-treated patients. Results of a double-blind cross-over study.
    Vahlquist C; Olsson AG; Lindholm A; Vahlquist A
    Acta Derm Venereol; 1995 Sep; 75(5):377-80. PubMed ID: 8615057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
    Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy.
    Blair SN; Capuzzi DM; Gottlieb SO; Nguyen T; Morgan JM; Cater NB
    Am J Cardiol; 2000 Jul; 86(1):46-52. PubMed ID: 10867091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxide-dependent amino acid oxidation and chemiluminescence catalysed by magnesium-pyridoxal phosphate-glutamate complex.
    Meyer BU; Schneider W; Elstner EF
    Biochem Pharmacol; 1992 Aug; 44(3):505-8. PubMed ID: 1510700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidemic and Hepatoprotective Effects of a Polyprenol-Containing Drug in Patients with Acute Coronary Syndrome.
    Vyshlov EV; Tsoy EI; Sultanov VS; Trusov VB; Ryabov VV
    Bull Exp Biol Med; 2018 Jul; 165(3):319-321. PubMed ID: 29998439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring and treatment of dyslipidemia in predialysis patients with chronic renal failure].
    Małecki R
    Pol Arch Med Wewn; 2003 Oct; 110(4):1215-25. PubMed ID: 14699681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.